Blister Pack Label (Blister Pack)
Pylera Capsule
Product Images NDC 61269-381
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pylera (NDC 61269-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by H2-pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton Label (Carton)
This document provides a daily dosing schedule for PYLERA capsules, a combination therapy used for the eradication of Helicobacter pylori. Each capsule contains bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride along with various inactive ingredients. The capsules should be taken after meals and at bedtime according to the specified quantities. It also includes information on storage conditions and the manufacturer's details. Additionally, the text mentions that PYLERA does not contain omeprazole and is intended for the treatment of patients with H. pylori infection and duodenal ulcer disease.*
Metronidazole (Metronidazole)
Tetracycline Hydrochloride (Tetracycline Hydrochloride)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
